C-reactive protein causes insulin resistance in mice through fcg receptor IIB-mediated inhibition of skeletal muscle glucose delivery

Diabetes

Volumn 62, Issue 3, 2013, Pages 721-731

  Tanigaki, Keiji ^a,b   Vongpatanasin, Wanpen ^a   Barrera, Jose A ^a   Atochin, Dmitriy N ^b   Huang, Paul L ^c   Bonvini, Ezio ^d   Shaul, Philip W ^a,b   Mineo, Chieko ^a  

^a University of Texas   (United States)

^b Division of Cardiology (111A)   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Analytical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FC RECEPTOR IIB; GLUCOSE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER CELL; MALE; MOUSE; MUSCLE BLOOD FLOW; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROVESSELS; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SPECIFICITY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IGG; RECOMBINANT PROTEINS;

EID: 84874443856     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0133     Document Type: Article

References (28)

1. Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 2003;92:18J-26J
2. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47
3. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978
4. Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 2003;23:650-655
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334
6. Freeman DJ, Norrie J, Caslake MJ, et al.; West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596-1600
7. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2006;2: 195-211
8. Haffner SM. Abdominal adiposity and cardiometabolic risk: Do we have all the answers? Am J Med 2007;120(Suppl. 1):S10-S16; discussion S16-S17
9. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97(2A):3A-11A
10. Kahn SE, Zinman B, Haffner SM, et al.; ADOPT Study Group. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006;55:2357-2364
11. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 2008;456:989-992
12. Marnell L, Mold C, Du Clos TW. C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-111
13. Schwartz R, Osborne-Lawrence S, Hahner L, et al. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res 2007;100:1452-1459
14. Vongpatanasin W, Thomas GD, Schwartz R, et al. C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation 2007;115:1020-1028
15. Lin CS, Xia D, Yun JS, et al. Expression of rabbit C-reactive protein in transgenic mice. Immunol Cell Biol 1995;73:521-531
16. Xia D, Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci USA 1997;94:2575-2580
17. Schleicher M, Yu J, Murata T, et al. The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2009;2:ra41
18. Atochin DN, Wang A, Liu VW, et al. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 2007;117:1961-1967
19. Sundgren NC, Zhu W, Yuhanna IS, et al. Coupling of Fcg receptor I to Fcg receptor IIB by Src kinase mediates C-reactive protein impairment of endothelial function. Circ Res 2011;109:1132-1140
20. Vicent D, Ilany J, Kondo T, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003; 111:1373-1380
21. Cook S, Hugli O, Egli M, et al. Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 2004;53:2067-2072
22. Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6:924-928
23. Rogoff D, Ryder JW, Black K, et al. Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 2007;148:5072-5080
24. Somwar R, Koterski S, Sweeney G, et al. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 2002;277:50386-50395
25. Hill JW, Elias CF, Fukuda M, et al. Direct insulin and leptin action on proopiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab 2010;11:286-297
26. Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 2007;56:1025-1033
27. Steele R, Wall JS, De Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956;187:15-24
28. Chuang JC, Cha JY, Garmey JC, Mirmira RG, Repa JJ. Research resource: Nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol 2008;22:2353-2363